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Abstract
Monoclonal nonspecific suppressor factor (MNSF), a lymphokine produced by murine T cell hybridoma, possesses a
pleiotropic antigen-nonspecific suppressive function. We have shown that 70 kDa MNSF comprises an 8 kDa ubiquitin-
like polypeptide (Ubi-L) and 62 kDa T cell receptor (TCR) K-like molecule. Ubi-L binds specifically to its 82 kDa receptor
protein on target cells. In the current study, we have further characterized the biochemical nature of the TCRK-like
molecule. The 62 kDa protein was separated into two species of 46 kDa and 16 kDa on reverse-phase HPLC. Anti-TCRK
monoclonal antibody recognized the 46 kDa, but not the 16 kDa protein. Anti-TCRL monoclonal antibody failed to
recognize these proteins. Ubi-L conjugated to the 46 kDa protein, whereas Ubi-L lacking its C-terminal Gly-Gly did not.
Although Ubi-L was labile both to heating at 56‡C and to acidification to pH 4, the Ubi-L-46 kDa protein complex was
unaffected by these treatments. In addition, the 46 kDa protein elongated the Ubi-L-induced protein tyrosine
phosphorylation in a concanavalin A-activated murine T helper type 2 clone, D10 cells. One of the four tryptic peptide
sequences derived from the 46 kDa protein was in alignment with a related sequence found in the JK region of the TCRK,
including the highly conserved motif F-G-X-G-T-X-L. A 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The 76-residue protein ubiquitin is a highly con-
served protein, with only three conservative changes
between yeast and human. Ubiquitin is involved in
the degradation of short-lived or structurally abnor-
mal proteins [1]. The process is accomplished
through a unique post-translational modi¢cation in
which the carboxyl terminus (Gly-Gly doublet) of
ubiquitin is covalently ligated to lysine O-amino
groups of acceptor proteins. Other cellular processes
in which the ubiquitin system is also involved include
DNA repair [2], cell cycle progression [3], stress re-
sponse [4], ribosome biogenesis [5], antigen process-
ing [6], and regulation of the transcriptional nuclear
factor-UB [7]. In addition, several transducing recep-
tors, in particular the j-subunit of the T cell receptor
(TCR)-CD3 complex [8], the high a⁄nity IgE recep-
tor [9], tumor necrosis factor receptor [10], platelet-
derived growth factor receptor [11], and prolactin
receptor [12], are ubiquitinated receptors.
Monoclonal nonspeci¢c suppressor factor (MNSF)
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is a product of a concanavalin A (Con A)-activated
murine hybridoma that inhibits the generation of
lipopolysaccharide (LPS)-induced immunoglobulin-
secreting cells, proliferation of mitogen-activated T
and B cells, and interleukin (IL)-4 secretion by a
type 2 helper T cell clone [13,14]. MNSF (70 kDa)
comprises an 8 kDa ubiquitin-like polypeptide (Ubi-
L) and a 62 kDa TCRK-like molecule (MNSFK) [15].
We have cloned a cDNA encoding Ubi-L [16], which
is responsible for the biological activity [17]. To date,
isolation of cDNA encoding MNSFK has been un-
successful because of a transient and faint expression
of the mRNA. Like MNSF, Ubi-L inhibits IgE and
IgG1 production by LPS-activated B cells and divi-
sion in various tumor cell lines of murine origin.
Recently, we have characterized the biochemical na-
ture of Ubi-L receptor protein on T helper type 2
clone D10 [18]. We have also demonstrated the role
of protein tyrosine phosphorylation in Ubi-L medi-
ated signal transduction of D10 cells [19].
In the present study, we demonstrate that the 62
kDa TCRK-like protein consists of a 46 kDa protein,
which is serologically related to TCRK, and a 16 kDa
polypeptide. We also describe how Ubi-L speci¢cally
conjugates to the 46 kDa polypeptide.
2. Materials and methods
2.1. Ubi-L preparation
Recombinant Ubi-L was obtained as previously
described [16]. Brie£y, Ubi-L was expressed as a
fusion protein with glutathione S-transferase using
the pGEX-2T vector (Pharmacia, Piscataway, NJ,
USA). The ubiquitin-like segment was cleaved
from the fusion partner by thrombin and puri¢ed
using anti-PU1 antibody (Ab) coupled to Sephar-
ose 4B (Pharmacia). In some experiments, GST-
Ubi-L-p46 complex was obtained (see Section 3)
and the Ubi-L-p46 form was prepared as described
above.
2.2. Preparation of subunits of MNSFK
A⁄nity puri¢ed 62 kDa MNSFK was obtained as
reported [15]. The 62 kDa MNSFK was dialyzed
against 1 M acetic acid and lyophilized. The residue
was dissolved in 500 Wl of 0.1% tri£uoroacetic acid
(TFA) and the solution was injected into a reverse-
phase HPLC column (TSK ODS-120T, Tosoh, To-
kyo, Japan). Fractionation required a 30 min elution
with 0.1% TFA to 0.1% in 100% acetonitrile at a
£ow rate of 0.8 ml/min. Major peak fractions (p46
and p16) were lyophilized and subjected to SDS^
PAGE as described below.
2.3. Biotinylation of acetonitrile-puri¢ed species
(p46 and p16)
Either p46 (5 Wg) or p16 (10 Wg) was mixed with a
20-fold molar excess of NHS-LC-biotin in 1 ml of
0.01 M sodium phosphate, 0.15 M NaCl, and 0.1
mM PMSF, pH 7.2. Incorporation of biotin into
GST-Ubi-L was determined by the HABA (2-(4P-
hydroxyazobenzene)benzylic acid) assay [20], per-
formed according to the manufacturer’s instructions
(Pierce, Rockford, IL, USA).
2.4. Immunoblotting
Both the acetonitrile-puri¢ed species were sub-
jected to 12% SDS^PAGE under reducing condi-
tions, and blotted onto nitrocellulose membranes.
The membranes were blocked with 5% bovine serum
albumin in PBS for 1 h and then washed three times
with PBS containing 0.1% Tween 20 (PBS/Tween
20). Subsequently, the membranes were incubated
with anti-TCRK monoclonal Ab (mAb) (H28) in
PBS/Tween 20 for 2 h. Excess H28 was washed out
with PBS/Tween 20. The membranes were then in-
cubated with the peroxidase-conjugated IgG of anti-
hamster IgG (Cappel, Cochranvile, PA, USA) for 2 h.
After incubation, the membranes were again washed
with PBS/Tween 20 and developed using ECL re-
agents (Amersham Pharmacia Biotech). In some ex-
periments, anti-TCRL mAb was employed as ¢rst
Ab. Determination of the activation of protein tyro-
sine kinase was carried out with anti-phosphotyro-
sine monoclonal Ab as described [19].
2.5. Bioassay for Ubi-L activity
The procedure used has been described previously
[14]. Brie£y, D10 cells were used 10^12 days after
stimulation with antigen. Cells were dispensed into
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microculture plates at a density of 1U105 cells/well.
IL-4 in supernatants was measured by ELISA.
2.6. Analysis of amino acid sequence
In order to obtain small peptides suitable for ami-
no acid sequence analysis, p46 and p16 were digested
with trypsin at an enzyme-to-substrate molar ratio of
1:100 at 37‡C for 4 h. Tryptic peptides were sepa-
rated by reverse-phase HPLC using a C18 column
equilibrated with 5% acetonitrile in 0.1% tri£uoro-
acetic acid. The column was developed with a 5^
60% linear gradient of acetonitrile for 120 min at
25‡C with a £ow rate of 1.0 ml/min. Peptides were
sequenced directly from PVDF membranes using an
ABI477 protein sequencer (ABI).
3. Results
We have mentioned previously that partially puri-
¢ed isopeptidase causes the dissociation of 70 kDa
MNSF into an 8 kDa ubiquitin-like polypeptide
(Ubi-L) and 62 kDa MNSFK, a TCRK-related mol-
ecule [15]. To further characterize the nature of 62
kDa MNSFK, reverse-phase HPLC (ODS 120T) was
carried out. MNSFK was subjected to the HPLC
column and eluted with a linear acetonitrile gradient,
yielding two major peaks, the ¢rst one eluting be-
tween 19 and 21 min and the second one eluting
between 27 and 29 min (Fig. 1). Fractions were
evaporated to dryness, resuspended in 10 mM Tris^
HCl (pH 6.8), and analyzed by immunoblotting with
mAbs to TCRs. The ¢rst peak showed a single band
with a molecular mass of 46 kDa (Fig. 2, lane 1). The
mass is similar to the expected mass of the full-length
TCRK chain [21]. Anti-TCRK mAb (H28), but not
anti-TCRL mAb (H57), recognized the 46 kDa pro-
tein (p46) (Fig. 2, lanes 2 and 5). The second peak
showed a band migrated at the position of 16 kDa
(Fig. 2, lane 4). Neither anti-TCRK nor anti-TCRL
mAb recognized the 16 kDa protein (p16) (Fig. 2,
lanes 3 and 6), indicative of the irrelevance of this
band to TCR molecules.
We next examined the reconstruction of MNSFK.
GST-Ubi-L (33.5 kDa) was mixed with biotinylated
p46 (bio-p46) or biotinylated p16 (bio-p16) in the
presence of murine splenocyte lysates [22]. The reac-
tion mixture was precipitated with streptavidin aga-
rose and subjected to SDS^PAGE. Immunoblotting
was then performed with the use of anti-GST Ab. As
Fig. 1. Analysis of the reverse-phase HPLC fractionation of
MNSFK. MNSFK puri¢ed by MO6 a⁄nity chromatography
was concentrated, dialyzed to a ¢nal concentration of 0.1%
TFA before loading on the ODS-120T column. Reverse-phase
HPLC was performed as described in Section 2. Fractions were
evaporated to dryness, resuspended in 10 mM Tris^HCl (pH
6.8), and subjected to SDS^PAGE.
Fig. 2. Immunoblotting analysis by anti-TCR Abs. Each frac-
tion on HPLC was separated on 12% SDS-polyacrylamide slab
gels. The proteins were blotted on nitrocellulose sheets and
were allowed to react with anti-TCR mAb and then with the
peroxidase-conjugated IgG of rabbit anti-hamster IgG. Antigen-
ic bands were visualized by the ECL system. Lanes 1, 2 and 5,
the ¢rst peak (p46); lanes 3, 4 and 6, the second peak (p16).
Lanes 1 and 4 were stained with Amide black; lanes 2 and 3,
anti-TCRK mAb; lanes 5 and 6, anti-TCRL. The positions of
p46 and p16 are indicated, as are the molecular mass standards
in kDa.
BBAMCR 14847 3-5-02
M. Nakamura et al. / Biochimica et Biophysica Acta 1589 (2002) 196^202198
depicted in Fig. 3A, a single band migrated at the
position of 80 kDa was determined when bio-p46
was employed (Fig. 3A, lane 2), suggestive of the
conjugation of bio-p46 to GST-Ubi-L. Bio-p46 did
not conjugate to GST-Ubi-L in the absence of sple-
nocyte lysates (lane 3). The addition of lysates from
Con A-activated (48 h) splenocytes had no e¡ect on
the Ubi-L conjugation (lane 4). Thus, it may be pos-
sible that enzyme(s) involved in the Ubi-L conjuga-
tion might present in unstimulated splenocytes. In
contrast, bio-p16 failed to bind to GST-Ubi-L in
the presence of unstimulated splenocyte lysates
(lane 5). To determine whether the COOH-terminal
Gly-Gly doublet of Ubi-L is necessary for Ubi-L
conjugation, we prepared a mutant Ubi-L containing
a substitution of Gly-74 with Ala at the COOH ter-
minus (Ubi-L-G74A). As can been seen in Fig. 3A,
biotinylated GST-Ubi-L-G74A did not conjugate to
p46 (lane 7), implying that the C-terminal Gly-Gly
doublet is important for Ubi-L conjugation. We also
determined whether partially puri¢ed isopeptidase
[15] dissociates Ubi-L from p46. GST-Ubi-L-p46
was obtained as described above and puri¢ed with
the use of glutathione Sepharose beads. As shown in
Fig. 3B, GST-Ubi-L was dissociated from p46 in the
presence of isopeptidase (lane 2). The dissociation
could not be observed in the presence of 5 mM
5,5P-dithio-bis(2-nitrobenzoic acid) (DTNB), an in-
hibitor of isopeptidase (lane 3), indicating that Ubi-
L may conjugate to p46 via an isopeptide bond.
Ubi-L tends to form self-aggregation due to its
strong hydrophobicity, whereas the Ubi-L-p46 com-
plex is stable. Thus, we speculated that p46 is a sub-
unit responsible for stabilization of Ubi-L in terms of
biological activity. To test this possibility, Ubi-L-p46
complex was prepared as described in Section 2 and
heated at 56‡C or acidi¢ed to pH 4. As shown in
Table 1, the complex form was stable both to heating
at 56‡C and to acidi¢cation to pH 4. It should be
noted that MNSF does not show a 100% suppression
[13]. In contrast, Ubi-L was inactivated by the heat-
ing or the acidi¢cation. In addition, p46 did not
Fig. 3. Reconstruction of MNSF by the use of GST-Ubi-L and
bio-p46. (A) GST-Ubi-L was mixed with biotinylated p46 (bio-
p46) or biotinylated p16 (bio-p16) in the presence of murine
splenocyte lysates. The reaction mixtures were applied to strept-
avidin-agarose and resolved on 12% SDS^PAGE gels under re-
ducing conditions. Immunoblotting was then carried out with
the use of anti-GST Ab. Lanes: 1, GST-Ubi-L; 2, GST-Ubi-L
was mixed with bio-p46; 3, the same as lane 2 but in the ab-
sence of splenocyte lysates; 4, the same as lane 2 but in the
presence of Con A-activated (48 h) splenocyte lysates; 5, the
same as lane 2 but mixed with bio-p16; 6, GST-Ubi-L-G74A;
7, GST-Ubi-L-G74A was mixed with bio-p46. (B) Biotinylated
GST-Ubi-L-p46 was incubated with or without isopeptidase in
50 mM Tris^HCl (pH 7.5), 1 mM PMSF, 2 mM DTT. Subse-
quently, the reaction mixtures were resolved on 12% SDS^
PAGE gels under reducing conditions, and transferred to nitro-
cellulose membranes. Biotinylated proteins were detected by
ECL system. Lanes: 1, untreated GST-Ubi-L-p46; 2, treated
with isopeptidase; 3, the same as lane 2 but in the presence of
5 mM DTNB. The positions of GST-Ubi-L-p46 complex and
GST-Ubi-L are indicated, as are the molecular mass standards
in kDa.
Table 1
E¡ect of physicochemical treatment on Ubi-L activitya
Treatment % suppression
Ubi-L-p46 Ubi-L
None 77 72
56‡C, 30 min 75 0
pH 4 73 0
aUbi-L-p46 and Ubi-L were heated at 56‡C for 30 min or acidi-
¢ed to pH 4 at 4‡C for 24 h, and then returned to pH 7. The
factors were sterilized and assayed for suppressive activity as
described in Section 2.
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show any suppressive activity. Accordingly, the for-
mation of Ubi-L-p46 complex may be important for
keeping its activity in vivo.
Most recently, we have reported that Ubi-L in-
duces protein tyrosine phosphorylation [19]. Thus,
we asked whether p46 may a¡ect tyrosine phosphor-
ylation. As shown in Fig. 4, Ubi-L-p46 induced ty-
rosine phosphorylation of 65 and 31 kDa proteins in
a concanavalin A-activated murine T helper type 2
clone, D10 cells, whereas p46 did not induce any
protein tyrosine phosphorylation. Although Ubi-L
showed a rapid induction of tyrosine phosphoryla-
tion as described previously, increased tyrosine phos-
phorylation by Ubi-L-p46 peaked by 30 min, de-
clined by 60 min, and disappeared after 120 min.
To investigate the biochemical nature of p46, we
attempted to analyze the amino acid sequence of this
polypeptide. The N-terminal amino acid sequence of
this protein could not be determined presumably be-
cause of acetylation. Thus this protein was digested
with trypsin, separated by reverse-phase HPLC, and
tryptic peptides were sequenced. As shown below,
three of the ¢ve peptide sequences derived from
p46 are in alignment with a related sequence found
in the constant region of TCRK. Anti-TCRK mono-
clonal antibody (H28) used in this study recognizes
the constant region of the TCRK chain, suggestive of
the cross-reactivity of this antibody. Interestingly,
tryptic peptide 1 has a homology with the JK region
of the TCRK [23], including the highly conserved
motif F-G-X-G-T-X-L (Table 2). We also analyzed
the amino acid sequence of p16. Tryptic peptide se-
quences of p16 did not show any homology with
proteins so far reported (Table 2). The function of
the novel 16 kDa polypeptide is unknown at present.
4. Discussion
In this report, we have shown that the 62 kDa
TCRK-like protein consists of 46 kDa and 16 kDa
proteins. Ubi-L preferentially conjugated to the 46
kDa protein (p46), but not to the 16 kDa protein
(p16), in the presence of murine splenocyte lysates
(Fig. 3). p46 is serologically related to TCRK, be-
cause anti-TCRK mAb recognizes this polypeptide
and because tryptic peptide sequences derived from
p46 are in alignment with a sequence found in the
Fig. 4. p46 elongates Ubi-L-induced protein tyrosine phosphor-
ylation. Con A-activated (48 h) D10 cells were stimulated with
Ubi-L (100 nM), Ubi-L-p46 (100 nM) and p46 (200 nM) for
the indicated times. Equal amounts of whole cell lysates were
analyzed by immunoblot analysis using anti-phosphotyrosine
Ab as described in Section 2. The positions of p65 and p31 are
indicated, as are the molecular mass standards in kDa.
Table 2
Alignment between the amino acid sequence derived from p46
and the corresponding sequences from the open reading frame
of cloned murine T cell receptor
All alignments are between sequences of tryptic peptides from
p46 with internal sequences of the cloned murine gene. p46
peptide fragments were generated by trypsin treatment as de-
scribed in Section 2. The FGXGTXL motif is shown by aster-
isks. Similarly, p16 peptide fragments were generated and se-
quenced.
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open reading frame predicted by the cDNA sequence
of the cDNA encoding the TCRK chain. Recently,
we have demonstrated that Ubi-L binds speci¢cally
to target cells, a murine T helper type 2 clone, D10
[18]. In addition, we observed that Ubi-L receptor
ligation induced tyrosine phosphorylation of intracel-
lular proteins in D10 cells [19]. In this study, we
found that p46 is involved in the stability of Ubi-L
(Table 1) and the prolongation of Ubi-L induced
protein tyrosine phosphorylation (Fig. 4). We are
attempting to investigate whether p46 might contrib-
ute to the Ubi-L binding to D10 cells. Ubi-L-G74A
lacking C-terminal Gly-Gly did not conjugate to p46
(Fig. 3A). Like ubiquitin, the Gly-Gly doublet might
be responsible for the formation of an isopeptide
bond between the p46 Lys residue and the C-termi-
nus of Ubi-L. This argument is consistent with the
observation that partially puri¢ed isopeptidase disso-
ciated Ubi-L from p46 (Fig. 3B).
It has been claimed that suppressor factors consist
of e¡ector and accessory molecules [24]. Like MNSF,
these molecules are serologically related to the TCRK
chain. Although a number of suppressor factors have
been isolated and characterized, the genes that en-
code them have not been clearly de¢ned. We spec-
ulate that Ubi-L may be an e¡ector and p46 might
be an accessory molecule. Support for this theory is
the fact that p46 did not show any biological activity
(Table 1).
A number of ubiquitin-like proteins have been
identi¢ed that can be conjugated to proteins. Of
these, SUMO-1 (small ubiquitin-related modi¢er)
has been extensively characterized. The targets of
SUMO-1 are RanGAP1 [25], a nucleocytoplasmic
transport protein, p53 [26] and IUB [27]. SUMO-1
attaches to these substrates in a similar manner to
that of ubiquitination. Identi¢cation and character-
ization of enzymes involved in the Ubi-L conjugation
are under way to clarify the mechanism of action of
Ubi-L.
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